65岁以下移位股骨颈骨折的ORIF或关节置换:一项经济学决策分析
研究采用马尔可夫决策分析模型,模拟40至65岁移位股骨颈骨折患者行ORIF、全髋关节置换(THA)或半髋关节置换后的结局。结果显示,THA对于年龄>54岁的健康患者、>47岁的轻度合并症患者和>44岁的多重合并症患者具有成本效果。半髋关节置换结局更差且费用更高,不推荐用于该年龄组。
要点
- THA对>54岁健康、>47岁轻度合并症、>44岁多重合并症患者具成本效果。
- 40至65岁患者THA与ORIF平均临床结局相似,但ORIF结局变异性更大。
- 半髋关节置换在所有年龄和病例中结局更差且费用更高,不推荐用于该年龄组。
核心结论
- 与ORIF相比,初次THA对45至65岁移位股骨颈骨折患者可能具有成本效果,随着合并症和ORIF固定失败风险增加, favoring THA的年龄截点降低。
- 半髋关节置换结局更差且费用更高,不推荐用于该年龄组。
研究设计与样本
- 研究采用马尔可夫决策分析模型,模拟40至65岁发生移位股骨颈骨折患者行ORIF、全髋关节置换或半髋关节置换后的结局。
- 模型变量取自高级别证据研究和文献中报告的国家登记数据,采用敏感性分析和概率统计分析检验结果。
主要发现
- THA对>54岁的其他方面健康患者、>47岁的轻度合并症患者和>44岁的多重合并症患者是具有成本效果的选项。
- THA与ORIF在40至65岁患者的平均临床结局相似,但ORIF结局基于初始固定成功或失败具有更宽变异性。
- 半髋关节置换在所有年龄和病例中与更差结局和更高费用相关。
关键数值与推荐
- THA具有成本效果的年龄阈值:其他方面健康患者>54岁,轻度合并症患者>47岁,多重合并症患者>44岁。
- 证据等级:经济与决策分析Level III。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The decision between open reduction and internal fixation (ORIF) and arthroplasty for a displaced femoral neck fracture in a patient ≤65 years old can be challenging. Both options have potential drawbacks; if a fracture treated with ORIF fails to heal it may require a revision operation, whereas a relatively young patient who undergoes arthroplasty may need revision within his/her lifetime. The purpose of this study was to employ decision analysis modeling techniques to generate evidence-based treatment recommendations in this clinical scenario. METHODS: A Markov decision analytic model was created to simulate outcomes after ORIF, total hip arthroplasty (THA), or hemiarthroplasty in patients who had sustained a displaced femoral neck fracture between the ages of 40 and 65 years. The variables in the model were populated with values from studies with high-level evidence and from national registry data reported in the literature. The model was used to estimate the threshold age above which THA would be the superior strategy. Results were tested using sensitivity analysis and probabilistic statistical analysis. RESULTS: THA was found to be a cost-effective option for a displaced femoral neck fracture in an otherwise healthy patient who is >54 years old, a patient with mild comorbidity who is >47 years old, and a patient with multiple comorbidities who is >44 years old. The average clinical outcomes of THA and ORIF were similar for patients 40 to 65 years old, although ORIF had a wider variability in outcomes based on the success or failure of the initial fixation. For all ages and cases, hemiarthroplasty was associated with worse outcomes and higher costs. CONCLUSIONS: Compared with ORIF, primary THA can be a cost-effective treatment for displaced femoral neck fractures in patients 45 to 65 years of age, with the age cutoff favoring THA decreasing as the medical comorbidity and risk of ORIF fixation failure increase. Hemiarthroplasty has worse outcomes at higher costs and is not recommended in this age group. LEVEL OF EVIDENCE: Economic and decision analysis Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Swart E, Roulette P, Leas D, et al. ORIF or Arthroplasty for Displaced Femoral Neck Fractures in Patients Younger Than 65 Years Old: An Economic Decision Analysis. J Bone Joint Surg Am. 2017. PMID: 28060235. doi:10.2106/JBJS.16.00406
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。